Mastering mAb Manufacture
Experts share their tips and tricks for enhancing the production of monoclonal antiboides
The monoclonal antibody (mAb) field has come a long way since the first therapeutic mAb was commercialized in 1986. As of today, over 60 mAbs have been approved in the US and Europe and sales of mAbs are expected to cross $125 billion by 2020. Efficient recovery and purification of mAbs from cell culture medium is a critical part of the production process and can contribute significantly to the total manufacturing costs. In this ebook, experts from GE Healthcare share their advice on chromatography resins and purification.
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.